Tuesday Health Unveils Groundbreaking Results from the ePAL Continuous Monitoring Study
Wednesday, August 14, 2024
Published in the Journal of Pain and Symptom Management, the Study Highlights Significant Advancements Using the ePAL App, now known as mytuesday, to Reduce Symptom Severity and Hospital Admissions
NASHVILLE, Tenn., Aug. 6, 2024 /PRNewswire/ -- Tuesday Health is thrilled to announce the publication of groundbreaking results from the ePAL randomized controlled trial, highlighting significant advancements in continuous monitoring for patients with serious illness. The study, published in the Journal of Pain and Symptom Management, showcases the efficacy of ePAL, a smartphone application leveraging patient-reported outcomes and artificial intelligence to optimize cancer pain management. Patients who received the ePAL app had significant improvements in pain and a marked 69% reduction in pain-related hospitalizations.
The ePAL study is a first-of-its-kind randomized controlled trial demonstrating that a digital continuous monitoring solution can reduce symptom burden and significantly reduce hospitalizations in patients with serious illness. The app, initially developed at the Mass General Brigham healthcare system, has been acquired and expanded by Tuesday Health as the "mytuesday" app, which comprehensively addresses the multitude of pain and non-pain symptoms that impact the quality of life and drive unwanted healthcare utilization in patients with all forms of serious illness.
The ePAL study enrolled 112 patients with pain from metastatic solid tumors, randomly assigning them to either a control group or an intervention group using ePAL for eight weeks. Both groups received usual oncologic and palliative care. Key findings include:
-- Significant Reduction in Pain Severity: Patients using ePAL reported a
significant 26% reduction in pain severity.
-- Improved Attitudes Toward Cancer Pain Management: Users of the app
reported feeling significantly more empowered to manage their cancer
pain.
-- Reduced Hospital Admissions: ePAL users had a 69% reduction in
pain-related admissions and an 82% reduction in pain-related admissions
through the emergency department.
"We are excited to share the results of this landmark randomized controlled study, which underscore the transformative potential of technology in enhancing serious illness care," said Dr. Mihir Kamdar, lead author and Head of Clinical Delivery at Tuesday Health. "The significant reductions in symptom burden and hospital admissions highlight how integrating AI and continuous monitoring can help patients get the care they need in real-time. We look forward to continuing this journey by bringing our comprehensive 'mytuesday' digital supportive care solution to a broader population of seriously ill patients."
"Patients with serious illness struggle to find the symptom help they need at home and routinely end up in the ED or hospital," said Dr. Jacob Strand, Chair of Enterprise Center for Palliative Medicine at Mayo Clinic, study co-author, and clinical advisory board member of Tuesday Health. "The ePAL study demonstrates the promise of how a comprehensive continuous monitoring solution, like mytuesday, can create a digital safety net for patients with serious illness." The findings from the ePAL study pave the way for broader dissemination and implementation of the "mytuesday" app, particularly in settings with limited access to palliative care.
Jim Wieland, CEO of Tuesday Health, expressed his enthusiasm about the study's implications for patient care. "This study reaffirms our commitment to innovative, value-based care models that prioritize patient outcomes. The acquisition of ePAL and its expansion to the 'mytuesday' platform represents a significant step forward in our mission to transform the management of serious illnesses and improve the quality of life for patients and their families."
Tuesday Health remains dedicated to leveraging cutting-edge technology and evidence-based protocols to enhance patient care and support. For more information about the study and the "mytuesday" app, please visit www.TuesdayHealth.com
About Tuesday Health:
Tuesday Health is a value-based supportive care organization that delivers patient-directed, whole-person care and support for seriously ill patients and their caregivers. The company is dedicated to transforming supportive care through clinical expertise, industry-leading data, and technology. Launched in 2023, Tuesday Health was developed from a partnership of Valtruis and Mass General Brigham Ventures.
Media Contact
Kelli Campbell
Tuesday Health Communications
kcampbell@tuesdayhealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/tuesday-health-unveils-groundbreaking-results-from-the-epal-continuous-monitoring-study-302214773.html
SOURCE Tuesday Health
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Oracle Named a Leader in Configure, Price, Quote by Independent Research Firm | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
|
